ArticleCellular and molecular gastroenterology and hepatology2023

PFKFB4 Is a Metabolic Driver of HCC Progression and Chemoresistance Through ROS Mitigation.

Paula Olaizola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.